Humdum Durrani in Jonesboro, Arkansas

Home Arkansas Jonesboro

Humdum Durrani has Hematology as his primary medical specialty. Their primary office is: 225 E Jackson Ave in Jonesboro, Arkansas.

They're a part of the: Cancer Care Associates Inc medical group which has around 18 members. You can call their office at 870-207-8210 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 2007 (around 17 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Humdum P Durrani Office Phone and Directions

Humdum Durrani
Cancer Care Associates Inc
225 E Jackson Ave
Jonesboro, Arkansas 72401
870-207-8210

Patient Ratings
Please rate your experience with Humdum Durrani below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 870-207-8210

Enter a starting address:

Healthcare Info for Humdum Durrani

Medical School: Sorry, his university is not listed
Graduation Year: 2007
The Primary Medical Specialty for Humdum Durrani is listed as: Hematology
Approximate Years of Experience: 17
PAC (PECOS ID)#: 9830330851
NPI #: 1184861270
NPI Created On: 01/12/2009
NPI Last Updated Listed as: 09/15/2016
Primary Taxonomy Code: 207R00000X
License Number:
2011-01087
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Ambetter
QualChoice Life & Health Insurance Company, Inc.
Blue Cross Blue Shield
USAble Mutual Insurance Company
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, ENGL.

Services and Procedures include:

New patient office or other outpatient visit, typically 45 minutes
New patient office or other outpatient visit, typically 45 minutes
New patient office or other outpatient visit, typically 60 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 40 minutes
Established patient office or other outpatient, visit typically 40 minutes
Initial hospital inpatient care, typically 70 minutes per day

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787970121

Being Disputed:: No

Product Related: No

Payments Total: $11

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787970123

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $10

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787970125

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787970127

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Payments Total: $9

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787970129

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787970131

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Payments Total: $10

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787970133

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $3

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787970135

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Payments Total: $11

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787970139

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787970137

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Providers in Cancer Care Associates Inc

1.Isam Abdel-karim

225 E Jackson Ave
Jonesboro Ar 72401-3119
Cancer Care Associates Inc
Hematology/oncology

2.Hiba Ahmed

225 E Jackson Ave
Jonesboro Ar 72401-3119
Cancer Care Associates Inc
Radiation Oncology

3.Lori Black

225 E Jackson Ave
Jonesboro Ar 72401-3119
Cancer Care Associates Inc
Nurse Practitioner

4.Ashley Denton

225 E Jackson Ave
Jonesboro Ar 72401-3119
Cancer Care Associates Inc
Nurse Practitioner

5.Humdum Durrani

225 E Jackson Ave
Jonesboro Ar 72401-3119
Cancer Care Associates Inc
Hematology

6.Veronica Easton

225 E Washington Ave
Jonesboro Ar 72401-3111
Cancer Care Associates Inc
Internal Medicine

View all 18 members of Cancer Care Associates Inc medical group